RECENT SCHOLAR PUBLICATIONS
- Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial HypercholesterolemiaJWCM Mulder, TR Tromp, M Al-Khnifsawi, DJ Blom, K Chlebus, M Cuchel, ...JAMA cardiology 2024
- Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional studyKI Dharmayat, AJ Vallejo-Vaz, CAT Stevens, JM Brandts, ARM Lyons, ...The Lancet 403 (10421), 55-66 2024
- Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional studyK Inamdar Dharmayat, AJ Vallejo-Vaz, CAT Stevens, JM Brandts, ...Elsevier 2024
- Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in‐hospital and long‐term outcomes–from the ESC‐HFA EORP HeartA Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ...European Journal of Heart Failure 25 (9), 1571-1583 2023
- Updated analysis of the Egyptian familial hypercholesterolemia research forum registryA Reda, A Elbahry, S Rafla, I Daood, S Emil, M Sobhy, G Kazamel, ...Atherosclerosis 379, S121 2023
- Total cholesterol level in a sample of Egyptian children and the need for primordial prevention programsA Reda, G KazamelAtherosclerosis 379, S81 2023
- Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)M Rizzo, A Colletti, PE Penson, N Katsiki, DP Mikhailidis, PP Toth, ...Pharmacological research 189, 106679 2023
- The Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) Perspectives on the Usage of InclisiranAS Elserafy, A Bendary, A Elbahry, E Farag, T Mostafa, O Sanad, ...Cardiology and Therapy 11 (4), 461-471 2022
- Egyptian association for vascular biology and atherosclerosis (EAVA) consensus on the use of inclisiran in clinical practiceA Reda, A Shawky, A Elkersh, A Elbahry, E Farag, M Ashraf, A BendaryAtherosclerosis 355, 83 2022
- Egyptian atherosclerosis and vascular biology association consensus on the use of sodium glucose cotransporter-2 inhibitors in heart failure with reduced ejection fractionA Reda, A Shawky, A Elbahry, A Bendary, A Elkersh, E Farag, M AshrafAtherosclerosis 355, 249-250 2022
- Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)PE Penson, E Bruckert, D Marais, Ž Reiner, M Pirro, A Sahebkar, ...Journal of cachexia, sarcopenia and muscle 13 (3), 1596-1622 2022
- The risk factor profile in Egyptian patients with acute coronary syndrome: an observational studyAA Elkersh, A Reda, A SamirMenoufia Medical Journal 35 (2), 359 2022
- Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort studyTR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ...The Lancet 399 (10326), 719-728 2022
- A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure LongA Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ...European Journal of Heart Failure 24 (2), 335-350 2022
- Insights on COVID-19 Pathophysiology and treatmentMM Sebaiy, A Abdelmonem, A Reda, A Fathy, A Gamal, A Ahmed, ...J. Pharm. Res. Drug Safety 1, 1-19 2022
- A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomesA Reda, H Ragy, K Saeed, MA AlhussainiJournal of the Egyptian Public Health Association 96, 1-14 2021
- Egyptian atherosclerosis and vascular biology association consensus on the use of sodium glucose cotransporter-2 inhibitors in heart failure with reduced ejection fractionAS Elserafy, A Reda, E Farag, T Mostafa, N Farag, A Elbahry, O Sanad, ...Clinical Drug Investigation 41, 1027-1036 2021
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ...The Lancet 398 (10312), 1713-1725 2021
- Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk projectA Reda, A Bendary, A Elbahry, E Farag, T Mostafa, H Khamis, M Wadie, ...European Heart Journal 42 (Supplement_1), ehab724. 2396 2021
- Egyptian Association of Vascular Biology and Atherosclerosis Consensus on The Usage of SGLT2 Inhibitors in Heart FailureA Reda, AS Elserafy, E Farag, T Mostafa, N Farag, A Elbahary, O Sanad, ...European Heart Journal Supplements 23 (Supplement_D), suab069. 005 2021
